2026-9-7Growing clinical demand for assisted reproduction worldwide drives the expansion of urinary gonadotropin API market. Combined with the implementation of ICH Q14, international high-end markets have raised standards on impurity control and quality traceability. Chinese compliant manufacturers with complete quality systems are gaining increasing export orders.